Why the study?
The tricuspid valve has gained clinical and research interest due to growing recognition of the importance of right heart disease.
This review highlights the importance of the right heart as a single functioning unit and discusses current tricuspid regurgitation classification and treatment strategies.
Supports multimodal tricuspid regurgitation assessment; extends right heart unit framework but leaves transcatheter timing open to trials.
The Tricuspid Valve (TV) has been a subject of increasing clinical and research interest over the last century due to recognition of the importance of right heart (RH) disease. In this review we have emphasised the concept of the RH as a single functioning unit under normal and altered loading conditions. The complex structure of the RH is reflected in schematic illustrations to broaden understanding outside of the echo laboratory. We have examined the current TR classification model in pursuit of generating research into whether a separate "pacing lead TR" subtype should be considered. The impact of TR on outcomes and most of current treatment strategies have also been covered. We hope this can be widely utilised by internists, cardiologists, cardiac surgeons, general practitioners, and clinical cardiac physiologists alike.
No takes yet. Share an insight, caveat, or question.
Ashcroft et al. (2022) conducted a review in Tricuspid Regurgitation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: